158 related articles for article (PubMed ID: 29172291)
1. The Utilization of Karyotyping, iFISH, and MLPA for the Detection of Recurrence Genetic Aberrations in Multiple Myeloma.
Sommaluan S; Rerkamnuaychoke B; Pauwilai T; Chancharunee S; Onsod P; Pornsarayuth P; Chareonsirisuthigul T; Tammachote R; Siriboonpiputtana T
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3135-3142. PubMed ID: 29172291
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH).
Alhourani E; Rincic M; Othman MA; Pohle B; Schlie C; Glaser A; Liehr T
Mol Cytogenet; 2014; 7(1):79. PubMed ID: 25435911
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.
Zang M; Zou D; Yu Z; Li F; Yi S; Ai X; Qin X; Feng X; Zhou W; Xu Y; Li Z; Hao M; Sui W; Deng S; Acharya C; Zhao Y; Ru K; Qiu L; An G
Oncotarget; 2015 Oct; 6(33):34276-87. PubMed ID: 26416457
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.
Kosztolányi S; Kiss R; Atanesyan L; Gángó A; de Groot K; Steenkamer M; Jáksó P; Matolcsy A; Kajtár B; Pajor L; Szuhai K; Savola S; Bödör C; Alpár D
J Mol Diagn; 2018 Nov; 20(6):777-788. PubMed ID: 30096382
[TBL] [Abstract][Full Text] [Related]
5. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization for detecting chromosome abnormalities in myelodysplastic syndromes: A retrospective study.
Ai X; Li B; Xu Z; Liu J; Qin T; Li Q; Xiao Z
Medicine (Baltimore); 2021 May; 100(18):e25768. PubMed ID: 33950965
[TBL] [Abstract][Full Text] [Related]
6. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
[TBL] [Abstract][Full Text] [Related]
7. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
Kadam Amare PS; Jain H; Nikalje S; Sengar M; Menon H; Inamdar N; Subramanian PG; Gujral S; Shet T; Epari S; Nair R
Indian J Med Res; 2016 Oct; 144(4):536-543. PubMed ID: 28256461
[TBL] [Abstract][Full Text] [Related]
8. Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load.
Neben K; Jauch A; Hielscher T; Hillengass J; Lehners N; Seckinger A; Granzow M; Raab MS; Ho AD; Goldschmidt H; Hose D
J Clin Oncol; 2013 Dec; 31(34):4325-32. PubMed ID: 24145347
[TBL] [Abstract][Full Text] [Related]
9. Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells.
Kishimoto RK; de Freitas SL; Ratis CA; Borri D; Sitnik R; Velloso ED
Rev Bras Hematol Hemoter; 2016; 38(2):113-20. PubMed ID: 27208569
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic-activated cell sorting combined with multiplex ligation-dependent probe amplification for detecting molecular cytogenetic abnormalities in multiple myeloma].
Lei M; Ma L; Kuang L; Pang Y; Wu J; Xiao Z; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1332-5. PubMed ID: 22985577
[TBL] [Abstract][Full Text] [Related]
11. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
12. Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.
Cui J; Lv R; Yu T; Yan W; Xu J; Fan H; Li L; Liu Y; Du C; Deng S; Sui W; Xu Y; Yi S; Zou D; Qiu L; An G
Haematologica; 2024 Feb; 109(2):591-603. PubMed ID: 37534514
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
16. [Application of multiplex ligation-dependent probe amplification for rapid detection of aneuploidies in prenatal diagnosis].
Ma DY; Hu P; Zhang JJ; Yi L; Ji XQ; Yang C; Cheng J; Li L; Lin Y; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Oct; 28(5):543-7. PubMed ID: 21983731
[TBL] [Abstract][Full Text] [Related]
17. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
18. Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia.
Donahue AC; Abdool AK; Gaur R; Wohlgemuth JG; Yeh CH
Leuk Res; 2011 Nov; 35(11):1477-83. PubMed ID: 21764131
[TBL] [Abstract][Full Text] [Related]
19. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of the Clonal Fraction by Fluorescence In Situ Hybridization in Myelodysplastic Syndrome: Comparison With International Working Group Treatment Response Criteria.
Park JH; Kim M; Kong SY; Yoon SS; Lee DS
Arch Pathol Lab Med; 2016 Jun; 140(6):560-9. PubMed ID: 27232348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]